The VJ Sessions aim to bring together leading experts in the oncology community to support international collaboration and allow them to discuss what the latest advances in diagnosis & therapy actually mean in the clinic.

View our growing collection of on-demand roundtable discussions across a range of oncology specialties below or listen to the podcasts on the go.

Lung Cancer

Lung Cancer

02 Mar 20236PM GMT | 1PM EST | 10AM PST

Lung Cancer Sessions with BTOG: EGFR exon 20 insertion mutations

Sanjay Popat, Anna Minchom, Riyaz Shah, Alastair Greystoke

Topics: testing for EGFR exon 20 insertion mutations in the UK, front-line management of patients with these mutations, and how to treat patients beyond first-line therapy.

30 Aug 2022

Highlights in Lung Cancer from WCLC 2022 with Lizza Hendriks & Tiziana VavalĂ 

Lizza Hendriks, Tiziana Vavala
Topics: the use of sotorasib in KRASG12C-mutant non-small cell lung cancer, oligometastatic disease, trial updates from WCLC 2022

06 Jun 2022

Highlights in Lung Cancer from ASCO 2022 with Jia Luo and Julia Rotow

Jia Luo, Julia Rotow
Topics: developments in the use of immunotherapy for lung cancer as well as recent trials investigating EGFR- and KRAS-mutated NSCLC.
10 Feb 2022

BTOG 2022 UK panel discussion

Sanjay Popat, Anna Minchom, Robert Rintoul, Alastair Greystoke

Topics: The current state of UK lung cancer care, novel IO targets & therapeutic cancer vaccines and the deployment of genomic testing in the UK

24 Nov 2021

EGFR-mutated NSCLC

Ross Camidge, Rosario Garcia Campelo, Natasha Leighl, Alexander Spira

Topics: Latest advances in EGFR-mutated NSCLC care including considerations around EGFR testing, first-line treatment options, immunotherapy, management of brain metastases, surveillance on therapy, reprofiling, the latest clinical trial data and what is on the horizon.

14 Oct 2021

ESMO & WCLC 2021

Sanjay Popat, Fiona McDonald, Riyaz Shah, David Baldwin

Topics: Lung cancer screening in the UK, adjuvant radiotherapy, concomitant chemo-radiation, resected NSCLC data, molecular testing, POSEIDON & HER2-mutated NSCLC

21 Jul 2021

ASCO 2021

Melissa Johnson, Heather A. Wakelee, Lizza Hendriks
Topics: IMpower010, CTONG1103 & IMPACT; CheckMate 816 & biomarkers in the adjuvant setting; KRAS G12C, HER3 ADCs and EGFR exon 20
19 May 2021

BTOG 2021

Sanjay Popat, Samreen Ahmed, David Gilligan, Neal Navani
Topics: COVID-19, SBRT & pleural effusions, KRAS inhibitors & ADCs, radiotherapy, CheckMate 816 & ADAURA
17 Feb 2021


Daniel Tan, Melissa Johnson, Dean Fennell
Topics: KRAS G12C, mesothelioma, IO & biomarkers, neoadjuvant & adjuvant strategies and screening
14 Oct 2020

ESMO 2020

Solange Peters, Martin Reck, Sanjay Popat
Topics: Oncogene targeted therapy, post-op RT in NSCLC, IO advances in NSCLC & SCLC
Breast Cancer

Breast Cancer

26 Jan 2023

Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons

Sara M. Tolaney, Paolo Tarantino, Sarah L. Sammons
07 Oct 2022

Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja


06 Jun 2022

Examining DESTINY-Breast04 with Matteo Lambertini & Evandro de Azambuja

Matteo Lambertini, Evandro de Azambuja
Topics: Trial updates in the field of ADCs and CDK4/6 inhibitors

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter